Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04-Reference-Cited by-同舟云学术

Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04

Published:2020-09-14 Issue:11 Volume:36 Page:1847-1859
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Uemura Yukari¹^ORCID,Sone Teruki²,Tanaka Shiro³,Miyazaki Teruhiko⁴,Tsukiyama Mayumi⁴,Taguchi Akira⁵^ORCID,Soen Satoshi⁶,Mori Satoshi⁷,Hagino Hiroshi⁸,Sugimoto Toshitsugu⁹^ORCID,Fukunaga Masao²,Ohta Hiroaki¹⁰,Nakamura Toshitaka¹¹,Orimo Hajime¹¹,Shiraki Masataka¹²,

Affiliation:

1. Department of Data Science, Biostatistics Section, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

2. Department of Nuclear Medicine, Kawasaki Medical School, Okayama, Japan

3. Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University, Kyoto, Japan

4. Public Health Research Foundation, Tokyo, Japan

5. Department of Oral and Maxillofacial Radiology, School of Dentistry, Matsumoto Dental University, Nagano, Japan

6. Department of Orthopaedic Surgery and Rheumatology, Nara Hospital, Kindai University, Nara, Japan

7. Bone and Joint Surgery, Seirei Hamamatu General Hospital, Shizuoka, Japan

8. School of Health Science, Tottori University faculty of Medicine, Tottori, Japan

9. Eikokai Ono Hospital, Hyogo, Japan

10. International Medical Center, Fujita Health University, Aichi, Japan

11. Japan Osteoporosis Foundation, Tokyo, Japan

12. Department of Internal Medicine, Research Institute and Practice for Involutional Diseases, Nagano, Japan

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1816537

Reference46 articles.

1. Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

2. Benefits and Risks of Bisphosphonate Therapy for Osteoporosis

3. Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial

4. Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

5. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Bisphosphonate Therapy Reduce Overall Mortality in Patients With Osteoporosis? A Meta-analysis of Randomized Controlled Trials;Clinical Orthopaedics & Related Research;2024-08-22

2. Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene;Calcified Tissue International;2023-01-28

3. Influence of symptomatic periodontal disease on changes in skeletal bone density during medication therapy for osteoporosis in postmenopausal women: the Japanese Osteoporosis Intervention Trial (JOINT)-04 and JOINT-05;Archives of Osteoporosis;2021-12-27

4. Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study;Journal of Bone and Mineral Metabolism;2021-03-18